GRANTS

147 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2017 to fund four to six awards. The number of awards is contingent upon NIH appropriations.

Due Date: January 12, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33)

Sponsor: National Institute on Aging

Award: NIA intends to commit $3.2 million in FY 2017 to fund four to six awards. The number of awards is contingent upon NIH appropriations.

Due Date: January 12, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit $2.7 million in FY 2017 to fund six to eight awards.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)

Sponsor: National Institute on Aging

Award: NIA intends to commit up to $3 million (total costs) in FY 2017 to support up to seven awards. The number of awards is contingent upon NIH appropriations.

Due Date: February 10, 2017, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Clinical Trials for Frontotemporal Degeneration RFP

Sponsor: Alzheimer's Drug Discovery Foundation through a partnership with the Association for Frontotemporal Degeneration

Award: $500,000-$2 million

Due Date: Letter of Intent: November 15, 2016. Invited Full Proposal: February 15, 2017.

Animal and Biological Material Resource Centers (P40)

Sponsor: National Institutes of Health, Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

Emerging Global Leader Award (K43)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: December 14, 2016; December 14, 2017; and December 13, 2018, by 5 p.m. local time of applicant organization.

Microphysiological Systems (MPS) for Disease Modeling and Efficacy Testing (UG3/UH3)

Sponsor: National Institutes of Health; National Center for Advancing Translational Sciences (NCATS); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Environmental Health Sciences (NIEHS); National Institute of Neurological Disorders and Stroke (NINDS); Office of Research on Women’s Health (ORWH); National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Heart, Lung, and Blood Institute (NHLBI)

Award: NCATS and participating ICs intend to commit $13.5 million in FY17 to fund 10-12 awards. NIBIB intends to commit an estimated total of $250,000 in FY2017 toward funding one award. NHLBI intends to commit up to $3 million in total costs per year for fiscal years 2017 through 2021 to fund up to two awards.

Due Date: December 13, 2016, by 5 p.m. local time of applicant organization.

BD2K Support for Meetings of Data Science Related Organizations (U13)

Sponsor: National Institutes of Health

Award: NIH intends to fund approximately four to five awards, corresponding to $2 million in total costs in fiscal year 2017. Since the nature and scope of the proposed conferences/scientific meetings will vary from application to application, it is anticipated that the size and duration of each award could vary.

Due Date: December 15, 2016; November 31, 2018, by 5 p.m. local time of applicant organization.

Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01)

Sponsor: National Institute on Aging

Award: For Fiscal Year 2017, NIA intends to fund three to five awards and has set aside $2.25 million. In future years, the number of awards will be contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

Centers of Excellence in Genomic Science (CEGS) (RM1)

Sponsor: National Human Genome Research Institute

Award: The NHGRI anticipates supporting not more than approximately ten CEGS projects at any one time and therefore not more than two awards will generally be made in any given year. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received, and the existing investment in the program. Although the financial plans of NHGRI provide support for this program, awards pursuant to this funding opportunity are contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: May 23, 2017; May 21, 2018; May 20, 2019, by 5 p.m. local time of applicant organization.

Current Filters

No filters selected

Filter By